Implications for immunosurveillance of altered HLA class I phenotypes in human tumours F Garrido, F Ruiz-Cabello, T Cabrera, JJ Perez-Villar, M López-Botet, ... Immunology today 18 (2), 89-95, 1997 | 1041 | 1997 |
Natural history of HLA expression during tumour development F Garrido, T Cabrera, A Concha, S Glew, F Ruiz-Cabello, PL Stern Immunology today 14 (10), 491-499, 1993 | 603 | 1993 |
Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles MI Lucena, M Molokhia, Y Shen, TJ Urban, GP Aithal, RJ Andrade, ... Gastroenterology 141 (1), 338-347, 2011 | 509 | 2011 |
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape I Algarra, A García-Lora, T Cabrera, F Ruiz-Cabello, F Garrido Cancer Immunology, Immunotherapy 53, 904-910, 2004 | 394 | 2004 |
Rexpression of HLA class I antigens and restoration of antigen‐specific CTL response in melanoma cells following 5‐aza‐2′‐deoxycytidine treatment A Serrano, S Tanzarella, I Lionello, R Mendez, C Traversari, ... International journal of cancer 94 (2), 243-251, 2001 | 293 | 2001 |
Analysis of HLA-E expression in human tumors R Marín, F Ruiz-Cabello, S Pedrinaci, R Méndez, P Jiménez, ... Immunogenetics 54, 767-775, 2003 | 233 | 2003 |
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 … CM Cabrera, P Jimenez, T Cabrera, C Esparza, F Ruiz‐Cabello, ... Tissue antigens 61 (3), 211-219, 2003 | 206 | 2003 |
Immune escape of cancer cells with beta2‐microglobulin loss over the course of metastatic melanoma AB Del Campo, JA Kyte, J Carretero, S Zinchencko, R Méndez, ... International journal of cancer 134 (1), 102-113, 2014 | 192 | 2014 |
Mutations of the β2‐microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides R Benitez, D Godelaine, MA Lopez‐Nevot, F Brasseur, P Jimenez, ... Tissue antigens 52 (6), 520-529, 1998 | 185 | 1998 |
MHC class I antigens and immune surveillance in transformed cells N Aptsiauri, T Cabrera, A Garcia‐Lora, MA Lopez‐Nevot, F Ruiz‐Cabello, ... International review of cytology 256, 139-189, 2007 | 177 | 2007 |
HLA class I antigens in human tumors F Garrido, T Cabrera, MA Lopez-Nevot, F Ruiz-Cabello Advances in cancer research 67, 155-195, 1995 | 177 | 1995 |
Role of altered expression of HLA class I molecules in cancer progression N Aptsiauri, T Cabrera, R Mendez, A Garcia-Lor, F Ruiz-Cabello, ... Immune-Mediated Diseases: From Theory to Therapy, 123-131, 2007 | 175 | 2007 |
Rejection versus escape: the tumor MHC dilemma F Garrido, F Ruiz-Cabello, N Aptsiauri Cancer immunology, immunotherapy 66, 259-271, 2017 | 170 | 2017 |
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy R Carretero, JM Romero, F Ruiz-Cabello, I Maleno, F Rodriguez, ... Immunogenetics 60, 439-447, 2008 | 169 | 2008 |
Coordinated downregulation of the antigen presentation machinery and HLA class I/β2‐microglobulin complex is responsible for HLA‐ABC loss in bladder cancer JM Romero, P Jiménez, T Cabrera, JM Cózar, S Pedrinaci, M Tallada, ... International journal of cancer 113 (4), 605-610, 2005 | 167 | 2005 |
Multiple mechanisms underlie HLA dysregulation in cervical cancer CS Brady, JS Bartholomew, DJ Burt, MF Duggan‐Keen, S Glenville, ... Tissue antigens 55 (5), 401-411, 2000 | 165 | 2000 |
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas MA Lopez-Nevot, F Esteban, A Ferron, J Gutierrez, MR Oliva, C Romero, ... British journal of cancer 59 (2), 221-226, 1989 | 162 | 1989 |
Analysis of HLA expression in human tumor tissues T Cabrera, M López-Nevot, J Gaforio, F Ruiz-Cabello, F Garrido Cancer Immunology, Immunotherapy 52, 1-9, 2003 | 158 | 2003 |
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes M Bernal, F Ruiz-Cabello, A Concha, A Paschen, F Garrido Cancer immunology, immunotherapy 61, 1359-1371, 2012 | 152 | 2012 |
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors P Jiménez, J Cantón, A Collado, T Cabrera, A Serrano, LM Real, A García, ... International journal of cancer 83 (1), 91-97, 1999 | 151 | 1999 |